High dose steroids (HDS), cyclosporine (CSA) and methotrexate (MTX) versus CSA and MTX as prophylaxis of graft versus host disease (GVHD) in HLA identical bone marrow transplantation (BMT).

被引：0
|
作者：
Macedo, MCMA [1 ]
Pallotta, RS [1 ]
Saboya, R [1 ]
Silva, RL [1 ]
Dzik, C [1 ]
Loterio, H [1 ]
Massumoto, CM [1 ]
Chamone, DAF [1 ]
Dulley, FL [1 ]
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,BMT PROGRAM,FUNDACAO PRO SANGUE HEMOCENTRO SAO PAULO,SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF METHOTREXATE (MTX), CYCLOSPORINE (CSA) AND COMBINED MTX AND CSA TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD)
    SPECK, B
    RINGDEN, O
    HOROWITZ, MM
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 582 - 582
  • [2] Comparison of cyclosporine (CSA) plus methylprednisolone (MePred) vs CSA plus methotrexate (MTX) for GvHD prophylaxis in HLA identical allogenic bone marrow transplantation (BMT)
    Zorsky, P
    Ballester, O
    Goldstein, S
    Hiemenz, J
    Janssen, W
    Fields, K
    Elfenbein, G
    BLOOD, 1995, 86 (10) : 1573 - 1573
  • [3] Bone marrow transplantation (BMT) for chronic myeloid leukemia (CML), the combination of cyclosporine (CSA), methotrexate (MTX) and prednisolone (MP) for prophylaxis of graft-versus-host disease (GVHD).
    Andrade, RJ
    Medeiros, CR
    ZanisNeto, J
    Ogasawara, VS
    Friedrich, MLC
    Bilencourt, MA
    Bonfirm, CMS
    Pasquini, R
    BLOOD, 1996, 88 (10) : 3769 - 3769
  • [4] GVHD PROPHYLAXIS FOR MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION (MUD) - COMPARISON BETWEEN CYCLOSPORINE-METHOTREXATE-METHYLPREDNISOLONE (CSA-MTX-MP) AND CSA-MTX
    LEELASIRI, A
    GREER, JP
    STEIN, RS
    GOODMAN, S
    EDWARDS, JR
    WOLFF, SN
    BLOOD, 1993, 82 (10) : A420 - A420
  • [5] Post-Transplant Cyclophosphamide Versus MTX-CSA As Gvhd Prophylaxis in HLA-Identical Sibling HSCT
    Bailen, Rebeca
    Pascual, Maria-Jesus
    Balsalobre, Pascual
    Gallardo-Morillo, Anabel
    Garcia-Sola, Abel
    Serrano, David
    Anguita, Javier
    Buno, Ismael
    Dorado Herrero, Nieves
    Solan, Laura
    Diez-Martin, Jose
    Kwon, Mi
    BLOOD, 2018, 132
  • [6] Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis
    Chen, George L.
    Zhang, Yali
    Liu, Hong
    Ross, Maureen
    Hahn, Theresa
    McCarthy, Philip L., Jr.
    BLOOD, 2011, 118 (21) : 1309 - 1310
  • [7] CSA vs CSA plus MTX in graft versus host disease prophylaxis in children with acute lymphoblastic leukemia transplanted from HLA identical sibling donors? Single center analysis
    Toporski, J
    Gorczynska, E
    Dyla, A
    Turkiewicz, D
    Kalwak, K
    Chybicka, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S101 - S101
  • [8] CYCLOSPORINE (CSA) VERSUS CYCLOPHOSPHAMIDE (CY) - PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD)
    SANTOS, GW
    BROOKMEYER, R
    SARAL, R
    TUTSCHKA, PJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 427 - 427
  • [9] Methotrexate and low-dose cyclosporine compared with cyclosporine alone for graft versus host disease prophylaxis in bone marrow transplantation
    Martin, C
    delaTorre, MJ
    Sanchez, J
    Martinez, F
    Gomez, P
    Torres, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 962 - 962
  • [10] Quadruple therapy with CsA, MTX, MMF and ATG and triple therapy with CsA, MTX and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation
    Fan, ZP
    Yi, ZS
    Liu, QF
    Sun, J
    Xu, D
    Zhang, Y
    Wei, YQ
    Ye, CX
    BLOOD, 2005, 106 (11) : 408B - 409B
12345